NCT01681199View on ClinicalTrials.gov

Fluvastatin AmelIorates aTHerosclerosis Study

PHASE4UnknownINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

August 31, 2014

Conditions

Coronary Heart DiseaseAtherosclerosis

Interventions

DRUG

Fluvastatin extended release tablet

Trial Locations (1)

100029

RECRUITING

Cardiology department ,Beijing Anzhen hospital, Beijing

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Beijing Anzhen Hospital

OTHER